Detering, Matthew <br/><br/>
Ageratum conyzoides L. inhibits 5-alpha-reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise healthy men in a double blind randomized placebo controlled clinical study.  [electronic resource] 

 -  BioFactors (Oxford, England)  Nov 2017 
 - 789-800 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1872-8081 
<br/><br/><label>Standard No.: </label>10.1002/biof.1389  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>5-alpha Reductase Inhibitors--isolation & purification<br/>Adult<br/>Aged<br/>Ageratum--chemistry<br/>Anti-Inflammatory Agents--isolation & purification<br/>Biomarkers--blood<br/>Blood Glucose--metabolism<br/>Cell Line<br/>Cholestenone 5 alpha-Reductase--genetics<br/>Dehydroepiandrosterone Sulfate--blood<br/>Dihydrotestosterone--blood<br/>Double-Blind Method<br/>Estradiol--blood<br/>Humans<br/>Hydrocortisone--blood<br/>Kallikreins--blood<br/>Male<br/>Middle Aged<br/>Plant Extracts--chemistry<br/>Prostate--drug effects<br/>Prostate-Specific Antigen--blood<br/>Prostatic Hyperplasia--blood<br/>Sex Hormone-Binding Globulin--genetics<br/>Testosterone--blood<br/>Treatment Outcome<br/>Urination--drug effects